Johannes Söllner
Sodatana has been founded and is solely run by Johannes Söllner. Johannes holds a PhD in genetics from the University of Vienna and has a proven scientific track record in bioinformatics and immunoinformatics method development and application. He has 20+ years in the biotech industry as employee and freelancer mostly supporting startups and a few established companies. Areas of work have mostly been selection and design of peptides, recombinant proteins and RNA, commonly but not exclusively for vaccines. Also a lot of data integration / data analysis / machine learning, a bit of IP related work as well as a number of data-platform & visualization, drug repurposing and therapeutic protein related projects. Admittedly for him the greatest joy lies in creative / innovative aspects, in close cooperation with experimental scientists and also IP attorneys.
Aside of this, Johannes believes in gentle but authentic and transparent relationships and the power of collaboration based on listening, intuition and respect. It is not just a phrase, you know.
Johannes Söllner
Founder and CEO of sodatana.
You can download Johannes Söllner's resume here.
A few selected publications
Selak Sanja, Triska Christine, Schuster Manfred,Söllner Johannes, Roppenser Bernhard, Weinhäupl Theresa, Rössler Max. WO 2021/165543 A1 (Patent Application). Propionibacterium Acnes Prophylactic and Therapeutic Immune Treatment. Filed: Feb 22, 2021, Published: Aug 26, 2021, Earliest Priority: Feb 21, 2020
Söllner J. Systems Vaccinology: Applications, Trends and Perspectives. Vaccine Design. Methods and Protocols: Volume 1: Vaccines for Human Diseases. 2016. ISBN 978-1-4939-3385-3
Synthetic lethality for linking the mycophenolate mofetil mode of action with
molecular disease and drug profiles. Mol Biosyst. 2012 Oct 30;8(12):3197-207.
doi: 10.1039/c2mb25256b. PubMed PMID: 23014771.
Lukas Arno, Soellner Johannes, Bernthaler Andreas, Mayer Bernd, Fechete Raul, Perco Paul, Heinzel Andreas (Patent Application). Critical gene targets for cytotoxic therapy. WO 2011/144738A1. application date: May 20, 2011
Söllner J, Heinzel A, Summer G, Fechete R, Stipkovits L, Szathmary S, Mayer B.
Concept and application of a computational vaccinology workflow. Immunome Res.
2010 Nov 3;6 Suppl 2:S7. doi: 10.1186/1745-7580-6-S2-S7. PubMed PMID: 21067549;
PubMed Central PMCID: PMC2981879.
[part of an Immunome Research special edition I edited]
Sollner J, Grohmann R, Rapberger R, Perco P, Lukas A, Mayer B. Analysis and
prediction of protective continuous B-cell epitopes on pathogen proteins.
Immunome Res. 2008 Jan 7;4:1. doi: 10.1186/1745-7580-4-1. PubMed PMID: 18179690;
PubMed Central PMCID: PMC2244602.
Johannes Söllner. Selection and combination of machine learning classifiers for prediction of linear B-cell epitopes on proteins. J Mol Recognit. 2006 May-Jun;19(3):209-14. doi: 10.1002/jmr.770.
Von Ahsen Uwe, Soellner Johannes, Weichhart Thomas, Hafner Martin (Patent Application) S. Aureus antigene. WO 2004/013166 A2; application Jul 22, 2003
One can access several of these and a number of my other publications on ResearchGate.